Bought
Maintained
Sold
Other funds holding NOV
Xponance's NOV Position: Q2 2026 in Review
Xponance reduced its NOV (NOV) stake by 0.57% in Q2 2026, selling an estimated $5.32K and leaving 46,258 shares worth $858K. The position accounts for 0.01% of the portfolio, ranked #849.
Xponance first reported a position in NOV in Q2 2020 and has held it in 24 quarters since. The position peaked at $1.08M in Q4 2022. 487 funds tracked by Wall St. Rank hold NOV as of Q2 2026.
- Xponance held 46,258 shares of NOV worth $858K as of Q2 2026.
- Xponance sold 267 NOV shares in Q2 2026, an estimated $5.32K.
- NOV made up 0.01% of Xponance's portfolio in Q2 2026, its #849 holding.
- Xponance first reported a position in NOV in Q2 2020 and has held it in 24 quarters since.
- Xponance's NOV position peaked at $1.08M in Q4 2022.
- 487 funds tracked by Wall St. Rank held NOV as of Q2 2026.
Based on Xponance's 13F filing for Q2 2026, filed 10 Aug 2026.